Reduction of High Risk Medications Using A Quality Initiative Perspective

Similar documents
Medication Use in Older Adults

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Geriatric Pharmacology

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Katee Kindler, PharmD, BCACP

Caroline S. Blaum, MD, MS Diane and Arthur Belfer Professor of Geriatrics Director, Division of Geriatric Medicine New York University Langone

Beers Criteria: Practical Considerations. A Clinician Education Tool. Curt Wood, RPh, CGP, FASCP

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Objectives. What are the Beers Criteria? Mark H Beers, MD Beers Criteria: History and Utilization 5/24/2016

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Integrating INTERACT into Interim Pharmacist Reviews

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter

Pharmacology in the Elderly

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

116th Annual Convention

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Capital Health Plan CMS Star Ratings Strategies for Improvement

January 16, Dear Administrator Verma:

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Medication Management When Caring for Seniors at Home

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Practical Management of the Delirious Patient with Mental Retardation by the Nurse Anesthetist

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island

9/11/2012. Clare I. Hays, MD, CMD

Anthony J. Caprio, MD, CMD, AGSF 1

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah

ADVANCED PRACTICE PROVIDER ROUNDS:

From Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events

The Path to Geriatric Sensitive Evidence - Based Care: Medications and Older Adults Barberton Hospital. Joyce Restifo MSN, RN Geriatric CNS-BC

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Institute of Quality Leadership AMGA

Updated Beers Criteria 2012 Potentially Inappropriate Medication Use in Older Adults

Review of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH

Medicare Part D Overutilization Monitoring System

Ensuring Safety of Anticoagulation Therapy

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES

spring 2015 You re in Charge and our online tools can support you - We protect your privacy - avoid high-risk medication - How to manage diabetes

Psychotropic Medications: What s New?

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

Arkansas Prescription Monitoring Program

Stronger together - optimizing pharmacotherapy on geriatric wards?

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

Telligen Quality Innovation Network Quality Improvement Organization

Fall Reduction in the Christus Santa Rosa ACE Unit

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Deprescribing Unnecessary Medications: A Four-Part Process

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Chitra Fernando, MD March 18, 2008

Monitoring Psychotropic Use Among Foster Children EMPAA

Hedis Behavioral Health Measures

Insomnia Agents (Sherwood Employer Group)

North Dakota Board of Pharmacy

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Trending Determinations by Measure

Interdisciplinary detection of potential drug related problems in older people

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State

Budnitz DS et al. NEJM Background

The Art of Communicating Geriatric Vital Signs (An Age Friendly Health System Approach)

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

Transforming Care for the Elderly

GRACE Team Care A New Model of Integrated Medical and Social Care for Older Persons

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Nortriptyline vs amitriptyline in elderly

ProviderNews FEBRUARY

Acute Care for Elders- Improving the Quality and Safety of Older Hospitalized Patients

Simple Steps for Quality Anticoagulation Therapy in LTC. Darren M. Triller, PharmD February 28, 2013

Medication Use in Older Adults: Updated AGS Beers Criteria

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

High Risk Medications: What Can Community Pharmacists Do to Make Patients Safer?

Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay

Tips and Tools to Drive Best Practice

Issues for Part D Compliance

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Improving Dementia Care in Nursing Homes Through Best Care Practices

PATIENT-IMPACT SCORECARD

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Management of Delirium in Hospice Patients

Transcription:

Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator

Objectives Learn what is a High Risk Medication (HRM) Learn the impact HRMs have on the elderly Learn successful strategies to promote reduction in the prescribing of HRMs in the elderly.

Community Care, Inc. Community Care is located in Eastern Wisconsin Three Programs PACE (federally managed) H5212 Frail elder Family Care Partnership (state based, FIDE-SNP) H2034 Frail elder, physically disabled, developmentally disabled H5207 Frail elder Family Care (state based long term care benefits) In PACE and Partnership, 1350 members are managed medically across nine counties

Problem Use/Over Use of medications identified as high risk when taken by members 65 or older compared to other plans. HEDIS: Healthcare Effectiveness and Data Information Set reporting identified poor performance compared to benchmarks for HRM prescribing rate for 2 consecutive years Measurement Years 2012 & 2013 Reported annually Data does not include PACE National Quality Forum (NQF) endorsed measure Drugs to Avoid in the Elderly (DAE) derived from AGS 2012 Beers Criteria

Problem Acumen LLC : Medicare vendor responsible for the accumulation and analysis of Prescription Drug Events (PDE) identified similar results to the HEDIS findings. HRM impacts plan STAR measures (not applicable to PACE)

What is a HRM? List of medications deemed potentially inappropriate (PIM) for individuals > 65 years Not DEFINITELY inappropriate American Geriatric Society (AGS) 2012 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults updated from original 1991 Beer s List Mark H Beers, Geriatrician

Beers List/HRMs Medications that can cause adverse drug events in older adults due to their pharmacologic properties and/or the physiologic changes associated with aging. Examples: muscle relaxants anticholinergics antihistamines certain oral hypoglycemics estrogens tertiary TCA s benzodiazepines non-benzodiazepine hypnotics

Impact of HRMs- Elderly Adverse central nervous system effects Orthostatic hypotension leading to FALLS Confusion leading to delirium Reduction of drug clearance Heart abnormalities- inducing failure Physical dependence Extrapyramidal effects GI bleeds

Understanding Rationale for Cost Prescribing of HRMs Member Satisfaction Lack of knowledge/awareness of possible adverse affects Reluctance to change a medications that s already working Lack of acceptable alternatives for some meds

HEDIS vs Acumen HEDIS Acumen Criteria Beer s Beer s Reporting Annually, previous year Monthly, current year Data Measures One prescription filled during a calendar year Two different prescriptions filled during a calendar year Two prescriptions of the same medication filled within the calendar year. Calculated by Member Years

High Risk Medication Rates HEDIS Results MY 2012 and 2013 2012 H5207 2013 H5207 2012 H2034 2013 H2034 HEDIS 50 th %ile benchmark HEDIS 75 th %ile benchmark HEDIS 90 th %ile benchmark High Risk Medication in the Elderly n=167 n=160 n= 77 n=85 One prescription 15.6% 20% 28.6% 18.8% 20.1 16.6 <13.9 Two or more prescriptions 5.4% 2.5% 9.1% 4.7% 6.0 4.7 <3.5 * Measurement years 2012 and 2013; PACE does not report on HEDIS measures **Benchmarks apply to 2013 HEDIS results

Acumen Patient Safety Analysis HRM PDE data MY 2013 CC PACE Contract MAPD Average

High Risk Medication Rates Acumen, LLC MY 2012 & 2013 2012 Contract Your Contract - HRM Rate Contract Type - Average HRM Rate Contract Performance Relative to Contract Type Average H2034 20.56 % 12.92 % Worse H5207 12.48 % 12.92 % Equal or Better H5212 PACE 12.75 % 12.92 % Equal or Better 2013 Contract Your Contract - HRM Rate Contract Type - Average HRM Rate Contract Performance Relative to Contract Type Average H2034 13.25 % 10.32 % Worse H5207 11.33 % 10.32 % Worse H5212 PACE 11.94 % 10.32 % Worse Note: Annual changes in Measure specifications apply to all plans

What to do? Establish a project team Primary Care Pharmacy Risk Quality Information Technology Develop Charter Employed PDSA principles Educated Project Team Beer s List

High Risk Medication Charter Goal: Improve safety by decreasing the use of High Risk Medications in Community Care s members 65 years and older. Target: Achieve a rate that is at or better than the national average for Medicare Advantage Plans HEDIS 50 th Percentile Benchmark by Measurement Year 2015 Acumen s MAPD Average Low Income Subsidy (LIS)

High Risk Medication Charter Scope: Prescribing and dispensing of HRMs using existing data sources, measures, and benchmarks to evaluate results Interventions affecting Primary Care & Pharmacy PACE and Partnership plan members Out-of-scope Additional $$$ or resources Community Care s Family Care members no prescription drug benefit

High Risk Medication Charter Dependencies - External prescribers - Potential impact on the prescribing and dispensing process. - Prescriber/member relationship Education - Primary Care (internal/external) - Interdisciplinary Care Team - Pharmacy Timeline - Minimum 12 months, with ongoing monitoring

PLAN-DO General education to Community Care s employed prescribers on the Beers Criteria. (April 2014) Laminated Beers Criteria distributed to providers and nursing staff (April/May 2014) General information letter w/ handy Beers Criteria pocket guide to all contracted & employed prescribers (June/July 2014)

PLAN-DO Identified four of the most problematic HRMs: amitriptyline (Elavil ) cyclobenzaprine (Flexeril ) zolpidem (Ambien ) glyburide (Diabeta )

PLAN-DO Involved Pharmacy Benefits Manager Created daily reports of HRMs dispensed to those > 65 years Uploaded reports to secure FTP site

Pharmacists PLAN-DO Reviewed the daily reports Sent alert letters to prescribers beginning September 2014 Identified patient & prescription Suggested alternatives to the HRM medication Offered Pharmacist consultations for more difficult HRM-related cases.

STUDY 120 110 113 Total # Prescriptions Dispensed for 4 Targeted HRMs* 100 90 80 70 60 Project team began Meeting PC Education on Beers Criteria Educational letter to Providers Letters to providers prescribing targeted meds Q1-2014 Q2-2014 Q3-2014 Q4-2014 *All PACE & Partnership Programs 66

ACT Plan again Added 4 more HRMs to targeted list (Jan. 2015) benztropine hydroxyzine digoxin > 0.125mg daily doxepin > 6mg daily Offered pharmacist consultation via telephone with prescriber following 3 letters (Jan. 2015) Instituted electronic Clinical Pharmacist Medication Reviews (May 2015) with HRM evaluation Consideration for alternatives

HEDIS Results for MY 2012-2014 High Risk Medication Rate-1 prescription 35.0% 30.0% 25.0% 2012 2013 2014 2014 50th %ile Benchmark 28.6% 20.0% 15.0% 10.0% 15.6% 20.0% 12.6% 18.8% 14.0% 5.0% 0.0% Lower is better CCI Partnership Plans only H5207 H2034

HEDIS Results for MY 2012-2014 High Risk Medication Rate-2 Prescriptions 10.0% 2012 2013 2014 2014 50th %ile Benchmark 8.0% 9.1% 6.0% 4.0% 5.4% 4.7% 2.0% 2.5% 3.2% 0.0% H5207 Lower is better CCI Partnership Plans only 0.6% H2034

Results 8 targeted Meds 80 70 60 50 40 30 20 10 0 74 Total # Prescriptions dispensed for 8 Targeted HRM 40 29 33 30 27 29 28 Jan-14 Jan-15 Feb Mar Apr May Jun July Aug 22 Project Team began meeting

Acumen Results 2015 High Risk Medication Rate Summary LIS Beneficiaries Jan. through Aug., 2015 Contract HRM Rate All Contracts 8% MAPDs 5% H2034 5% H5207 8% H5212-PACE 6%

Analysis What worked? Education of Prescribers on Beers Criteria Tangible reminders Pocket cards, laminated Beers List Focusing on a small group of higher volume medications Suggesting alternatives Pharmacist face-to-face consultations with patient and/or prescriber

Analysis-Challenges Repeated letters without pharmacist consultation Telephone calls to prescribers Tracking system--# letters sent compared to # times drugs dispensed Pharmacist availability to review alerts Various pharmacists interpreting significance of the HRM dispensed Caregiver reluctance to discontinue HRM

What s next? Continue to monitor and evaluate prescribing HRMs Add focused project on HRM drug/disease interactions 32% of CCI members have a dementia-related dx Promote non-pharmacologic approaches to behavioral and psychiatric symptoms of dementia (BPSD) Decrease use of antipsychotics in members with dementia

New Expanded 2015 Beer s List Intent Improve medication selection Educate clinicians and patients Reduce adverse drug events Serves as a tool for evaluating: Quality of care Cost Patterns of drug use J Am Geriatr Soc 2015.

For More Information 2015 Beers Criteria : list of medication combinations that may lead to harmful interactions medications that should be avoided or dosed differently for people with poor kidney function. Suggested alternative meds or treatment options http://www.americangeriatrics.org/press/id:5910 Patient Education: 10 Medications Older Adults should Avoid or Use with Caution (from Healthinaging.org) http://www.healthinaging.org/files/documents/tipsheets/meds_to_avoid.pdf

Share your story? Questions?